Motivation: Tumour Necrosis Factor alpha (TNF) initiates a complex series of biochemical events in the cell upon binding to its type R1 receptor (TNF-R1). Recent experimental work has unravelled the molecular regulation of the signalling complexes that lead either to cell survival or death. Survival signals are activated by direct binding of TNF to TNF-R1 at the cell membrane whereas apoptotic signals by endocytosed TNF/TNF-R1 complexes. Here we describe a reduced, effective model with few free parameters, where we group some intricate mechanisms into effective modules, that successfully describes this complex set of actions. We study the parameter space to show that the model is structurally stable and robust over a broad range of parameter values. Results: We use state-of-the-art Bayesian methods (a Sequential Monte Carlo sampler) to perform inference of plausible values of the model parameters from experimental data. As a result, we obtain a robust model that can provide a solid basis for further modelling of TNF signalling. The model is also suitable for inclusion in multi-scale simulation programs that are presently under development to study the behaviour of large tumour cell populations Availability: We provide supplementary material that includes all mathematical details and all algorithms (Matlab code) and models (SBML descriptions).
INTRODUCTION
Tumour Necrosis Factor alpha (TNF) is a cytokine that acts as a key regulator of immune functions (Tracey and Cerami, 1994; Ashkenazi and Dixit, 1998; Wallach et al., 1999) . TNF is the prototypical member of a growing family of cytokines (Locksley et al., 2001) but, unlike the other members, it can trigger intracellular signals that lead either to cell survival and proliferation or death (Tracey and Cerami, 1994; Ashkenazi and Dixit, 1998; Wallach et al., 1999; Locksley et al., 2001) . This dual role is * to whom correspondence should be addressed important in the regulation of immune response, because it provides a molecular basis to cellular homeostasis. These opposing signals might lead to inhibition of tumour growth or, on the contrary, to the promotion of tumour development through direct (see, e.g., Tucker et al. 2004 ) and indirect mechanisms (e.g., by tissue remodelling and stromal development. See, e.g., Balkwill 2002) . This motivates a detailed study of the molecular mechanisms involved in TNF signalling.
Many molecular actors of this complex intracellular machinery have been discovered and studied in a variety of cells (see Wajant et al., 2003, for a comprehensive review) . This has attracted the attention of modellers who have attempted to unravel the switching mechanism that leads either to cell survival or death, using standard methods of systems biology (Cho et al., 2003; Lipniacki et al., 2004; Eißing et al., 2004; Eißing and Allgöwer and E. Bullinger, 2005; Rangamani and Sirovich, 2007; Calzone et al., 2010) . They have mostly stressed the interplay among intracellular molecules and the network of reactions stimulated by the binding of TNF to its type 1 receptor (TNF-R1). Recent data show that the path that leads to cell survival is triggered by TNF binding to its receptor at the cell membrane, while the cell-death pathway is triggered by internalized TNF/receptor complexes (Micheau and Tschopp, 2003; SchneiderBrachert et al., 2004) . Here we focus on this important bifurcation and develop a reduced model of TNF action, and we use modern statistical techniques to estimate the model parameters.
MODEL OF TNF ACTION

Binding and internalization
A review of TNF signalling is provided in the supplementary material. Here we briefly recall that TNF is a homotrimeric molecule that binds to two different receptors, TNF-R1 and TNF-R2, and that TNF-R1 appears to be the key molecule in both normal and tumour cells. Current biochemical data show that the TNF-R1 receptors rapidly self-trimerize at the cell membrane because of the PreLigand Assembly Domain, and interact with TNF homotrimers (Chan et al., 2000) . The process of receptor trimerisation is Figure SF1 .
much faster than the binding kinetics, and the trimerised receptor behaves as an effective monomer, therefore TNF binding to TNF-R1 can be viewed as the result of a monomeric interaction between one molecule of TNF and one molecule of receptor. With this simplification we can drop 3 equations and 6 parameters from the model, and obtain a better identification of the remaining parameters.
Here we use an updated version of a model of Bajzer et al. (Bajzer et al., 1989; Vuk-Pavlović, S. and Kovach, J.S., 1989) to describe the early events of TNF interaction with cells. Bajzer et al. assumed that internalized ligand/receptor complexes could be recycled back to the cell surface, however recent data show that the final fate of the endosomes containing TNF complexes is to maturate to lysosomes by progressive fusion with vesicles from the trans-Golgi network loaded with lysosomal enzymes (Schneider-Brachert et al., 2004) , and it is very likely that TNF/TNF-R1 complexes do not recycle at all but are finally degraded into lysosomes. Therefore we modify the model as follows (see Figure 1 , and the supplementary material). We assume a steady flow of TNF receptors, so that their number in the cell membrane is held constant: this is described by the zeroorder rate constant Vr. The rate k d regulates the internalization of ligand-free TNF-R1 receptors. A receptor complex Rc forms at the cell membrane upon binding of TNF to TNF-R1, with rate constants kon and k off . This complex is internalized into cells (Rin) with rate constant kin, and the internalized ligand/receptor complexes can finally be degraded (R indeg ) with rate constant k deg . Figure 1 shows the modules that represent the main mechanisms triggered by TNF binding to its receptors. This is suggested by the recent work of Schneider-Brachert et al. (2004) that elegantly demonstrates that the pathway leading to NF-κB activation and cell survival is initiated at the cell membrane upon formation of TNF/TNF-R1 complexes, while the one that leads to apoptosis and cell death is initiated by complexes that are internalized into endocytic vescicles. In addition to the basic observations of Schneider-Brachert et al., we include the NF-κB-mediated transcription of genes coding for caspase-8 inhibitors such as FLIP. In this way, the intracellular pathways interact dynamically, because the cell survival pathway -that starts earlier since it does not require internalization of TNF/TNF-R1 complexes -can inhibit the apoptotic path. Here we model both biochemical circuits by means of only two modules, A and B, that denote the paths leading either to death or to cell survival, respectively. We assume that after the initial trigger both pathways proceed irreversibly to their endpoint. The production of B depends on the number Rc of TNF-TNF-R1 complexes on the cell membrane, with rate constant β. Likewise, the production of A depends on the number of internalized ligand/receptor complexes Rin, with rate constant α. The cell survival pathway inhibits the apoptotic reactions in A with rate γ [B] . Finally, molecules in both A and B can be degraded by means of ubiquitination and proteasome cleavage and/or irreversibly inhibited by other molecular species, and these processes are described by the rate constants k Adeg and k Bdeg , respectively. Eventually, we merge the necrotic and apoptotic paths introducing a single surviving fraction f (t). The complete model is:
Life and death pathways
where we have introduced the concentrations of free receptors (R f ) and free ligands (TNF) in addition to those defined above. At the population level, equation (1g) represents the dynamics of the surviving fraction f (t), while at the single-cell level f (t) can be interpreted as the probability that a cell is still alive at time t and κ[A] is the rate for a single-hit death mechanism: this notion is supported by a number of different cytotoxicity experiments, see, e.g., Lefkovits and Waldmann (1979); Neville Jr and Hudson (1986); Carmichael et al. (1993); Chapman (2003) ; Tubiana et al. (1990) . Notice also that if [A] is approximately constant in the time range (t, t + ∆t), we recover a familiar formula for the surviving fraction: f (t + ∆t) = f (t) exp(−κ[A]∆t). The complete list of parameters that we infer from experimental data is given in table ST1 in the supplementary material.
METHODS AND RESULTS
Bayesian inference
We split the analysis of the TNF signalling model in two stages. First we used the data of Grell et al. (1998) 
Binding and internalization kinetics
The first stage of our analysis requires the accurate knowledge of several experimental conditions, selecting the optimal experimental data is not trivial and requires careful inspection of an extensive scientific literature. Finally we chose the data of Grell et al. (1998) for the reasons given in the supplementary material. Figure 2 shows the data in Grell et al., along with the predictions drawn from our model, given the parameter posterior identified using this data set. Column 2 of table ST5 lists the maximum a posteriori (MAP) estimates of the relevant model parameters. It must be noted that existing data did not allow a unique parameter identification, and the resulting posterior has high variance. This result, however, is still useful, as it is used as a prior for the next stage of our analysis, where it is updated with more experimental data. A detailed description of the obtained posterior can be found in the supplementary material.
Dose/response cytotoxicity assays
Since Grell et al. did not report background values in their spectrophotometry measurements of cell viability, these data cannot be used for cytotoxicity estimates, and we take the data in Scherf et al. (1996) et al. (1998) . Units follow the specifications of tables ST2 and ST3, i.e., concentration in µM and and time in min. This figure is reproduced at a larger scale in the supplementary material, Figure SF2 . Table ST7 , we have computed the fraction of surviving cells has been computed after 1, 2, 4, 6, 8, . . . , 48 hours of treatment, for different initial TNF concentrations. For all times the response to TNF has a nearly sigmoid shape. This figure is reproduced at a larger scale in the supplementary material, Figure SF17 .
Model validation and robustness
Independent biochemical data on the expression kinetics of proteins in modules A and B were used to validate the prediction capabilities of the model (figures SF15 and SF16 in the supplementary material). Using the estimated parameters, we find that the surviving fraction after TNF administration is a nearly sigmoid function of the initial TNF concentration for all times (see figure 4 ). Thus the model provides a very specific prediction using the set of parameters from the Bayesian estimate, and we have investigated its robustness with respect to parameter changes, using the parameter values in tables ST7 and ST8 as starting points for the numerical study. There are 5 parameters that regulate the interplay of the A and B pathways, α, β, γ, k Adeg , and k Bdeg , while κ cannot influence the stability properties of the model. We carried out an extensive numerical exploration of this 5-dimensional parameter space, as a function of TNF concentration. To this end, parameters were varied on a regular logarithmic grid in a range corresponding to the extremes of the marginalised posterior distributions shown in figures SF8-SF11 in the supplementary material, scaled by 1 or 2 orders of magnitude in either direction (see figures SF18 and SF19 and the detailed description in the supplementary material). This analysis shows that the model does not change its qualitative behaviour even with very large parameters perturbations, that no unexpected and/or undesired patterns emerge, and that the model describes the balance between cell survival and death for a broad range of parameter values. We conclude that the model is structurally stable and robust (Strogatz, 1994) .
DISCUSSION
The modular model sketched in Figure 1 , and defined by equations (1a-1g) is a robust, structurally stable description of the dual TNF action. Although it replaces an accurate description of known mechanisms with effective actions, it provides a solid basis for more elaborate models, it establishes kinetic bounds for model parameters, and helps understand the differences in sensitivity to TNF of various cell lines. The model is also suitable for integration into complex multi-scale simulation programs of tumour growth such as VBL (Chignola and Milotti, 2004; Milotti and Chignola, 2010) , or other computational models (Jiang et al., 2005; Dionysiou and Stamatakos, 2006; Wang and Deisboeck, 2009) . We plan to use the model to explore in detail the response of tumour cell clusters to TNF therapy and to investigate tumour/immune system interaction dynamics.
